Role of phenotypic and genetic testing in managing clopidogrel therapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of phenotypic and genetic testing in managing clopidogrel therapy
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 5, Pages 689-699
Publisher
American Society of Hematology
Online
2014-06-21
DOI
10.1182/blood-2014-01-512723
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy
- (2013) Jean-François Tanguay et al. CANADIAN JOURNAL OF CARDIOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
- (2013) Udaya S. Tantry et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function
- (2013) Andrew L. Frelinger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- TheCYP2C19*17 variant is not independently associated with clopidogrel response
- (2013) J. P. Lewis et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
- (2013) Gregg W Stone et al. LANCET
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Platelet Function Testing and Genotyping Improve Outcome in Patients Treated With Antithrombotic Agents
- (2012) Paul A. Gurbel et al. CIRCULATION
- The Role of Platelet Reactivity and Genotype Testing in the Prevention of Atherothrombotic Cardiovascular Events Remains Unproven
- (2012) Vamsi Krishna et al. CIRCULATION
- The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
- (2012) Deepak L. Bhatt et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
- (2012) Dániel Aradi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention
- (2012) Matthew J. Price et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention
- (2012) Dimitrios Alexopoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
- (2012) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention
- (2012) Dobri Hazarbasanov et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
- (2012) Jason D Roberts et al. LANCET
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
- (2012) Jean-Philippe Collet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: A systematic review and meta-analysis
- (2012) Yusuke Yamaguchi et al. PLATELETS
- The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy
- (2011) Paul A. Gurbel et al. AMERICAN HEART JOURNAL
- Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention
- (2011) Matthew J. Price et al. CIRCULATION
- CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention
- (2011) Guillaume Paré et al. Circulation-Cardiovascular Interventions
- Modifying Clopidogrel Maintenance Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Improves Clinical Outcome in Patients With Clopidogrel Resistance
- (2011) Xiao-dong Wang et al. CLINICAL CARDIOLOGY
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity
- (2011) Dániel Aradi et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel
- (2011) Michel Zabalza et al. HEART
- The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial)
- (2011) Hasan Ari et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Cardiovascular Biomarker Conundrum
- (2011) Vinay Prasad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacogenomics and Clopidogrel
- (2011) Steven E. Nissen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention
- (2011) Somjot S. Brar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes
- (2011) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis
- (2011) Yan Ping Liu et al. THROMBOSIS RESEARCH
- Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
- (2010) Dániel Aradi et al. AMERICAN HEART JOURNAL
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) et al. CIRCULATION
- Assessing the Clinical Utility of Diagnostics Used in Drug Therapy
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
- (2010) R. Teng et al. DRUG METABOLISM AND DISPOSITION
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
- (2010) Nicoline J. Breet JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Case for Routine Genotyping in Dual-Antiplatelet Therapy
- (2010) Samir B. Damani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
- (2010) M. J. SORICH et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
- (2010) Bo Jin et al. MOLECULAR BIOLOGY REPORTS
- Biomarkers and surrogate end points—the challenge of statistical validation
- (2010) Marc Buyse et al. Nature Reviews Clinical Oncology
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
- (2010) F Sofi et al. PHARMACOGENOMICS JOURNAL
- Clopidogrel non-responsiveness and risk of cardiovascular morbidity
- (2010) Rossella Marcucci et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention
- (2009) Marco Valgimigli et al. CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
- (2009) Alan D. Michelson et al. EUROPEAN HEART JOURNAL
- Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
- (2009) C. Varenhorst et al. EUROPEAN HEART JOURNAL
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- (2009) Nagy A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement
- (2009) D. SIBBING et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
- (2008) Laurent Bonello et al. AMERICAN JOURNAL OF CARDIOLOGY
- Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders
- (2008) Thomas Cuisset et al. JACC-Cardiovascular Interventions
- Myocardial Ischemia and Infarction
- (2008) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance
- (2008) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started